Autobio Diagnostics Co (SHSE:603658) Change In Receivables : ¥0 Mil (TTM As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Autobio Diagnostics Co Change In Receivables?

Autobio Diagnostics Co's change in receivables for the quarter that ended in Mar. 2024 was ¥0 Mil. It means Autobio Diagnostics Co's Accounts Receivable stayed the same from Dec. 2023 to Mar. 2024 .

Autobio Diagnostics Co's change in receivables for the fiscal year that ended in Dec. 2023 was ¥-117 Mil. It means Autobio Diagnostics Co's Accounts Receivable increased by ¥117 Mil from Dec. 2022 to Dec. 2023 .

Autobio Diagnostics Co's Accounts Receivable for the quarter that ended in Mar. 2024 was ¥1,107 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Autobio Diagnostics Co's Days Sales Outstanding for the three months ended in Mar. 2024 was 92.73.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Autobio Diagnostics Co's liquidation value for the three months ended in Mar. 2024 was ¥77 Mil.

Autobio Diagnostics Co Change In Receivables Historical Data

The historical data trend for Autobio Diagnostics Co's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Autobio Diagnostics Co Change In Receivables Chart

Autobio Diagnostics Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

-394.47

-410.86

-57.76

-44.06

-117.26

Autobio Diagnostics Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Receivables	Get a 7-Day Free Trial															-	-	-	-	-

Autobio Diagnostics Co Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.

Autobio Diagnostics Co (SHSE:603658) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Autobio Diagnostics Co's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	1106.91	/	1089.195	*	91
=	92.73

2. In Ben Graham's calculation of liquidation value, Autobio Diagnostics Co's accounts receivable are only considered to be worth 75% of book value:

Autobio Diagnostics Co's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	1582.533	-	2752.064	+	0.75 * 1106.91	+	0.5 * 833.391
=	77

Autobio Diagnostics Co Change In Receivables Related Terms

Thank you for viewing the detailed overview of Autobio Diagnostics Co's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Autobio Diagnostics Co (SHSE:603658) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Autobio Diagnostics Co Ltd (SHSE:603658) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.199, 15th Avenue, National Economic and Technological Development Area, Zhengzhou, CHN, 450016

Website

http://www.autobio.com.cn

Autobio Diagnostics Co Ltd is a clinical diagnostics company in China. It specializes in research and development, production, marketing and service of clinical diagnostic products, including immunoassay, microbiology and biochemical products. It focuses on the common development of both reagents and instruments. Reagents products include immunoassay, biochemistry, microbiology, and IVD subdivision areas, and instruments include both full automation and semi-automation instruments and systems. Geographically it holds a strong distribution network with thousands of distributors in the Chinese market.

Executives

Miao Yong Jun

Director

Autobio Diagnostics Co (SHSE:603658) Headlines

No Headlines